Rockefeller Capital Management L.P. Novo Cure LTD Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Mar 06, 2023	SELL	$63.98 - $85.37 $501,987 - $669,813	-7,846 Reduced 85.97%	1,280 $93,000
Q2 2022 Aug 12, 2022	SELL	$56.6 - $89.9 $146,594 - $232,841	-2,590 Reduced 22.11%	9,126 $634,000
Q1 2022 May 13, 2022	BUY	$60.15 - $84.52 $4,210 - $5,916	70 Added 0.6%	11,716 $970,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $132,966 - $216,044	1,771 Added 17.93%	11,646 $874,000
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $1 Million - $1.68 Million	8,624 Added 689.37%	9,875 $1.15 Million
Q2 2021 Aug 10, 2021	BUY	$130.4 - $225.58 $37,164 - $64,290	285 Added 29.5%	1,251 $276,000
Q1 2021 May 11, 2021	SELL	$124.11 - $190.17 $1,489 - $2,282	-12 Reduced 1.23%	966 $127,000
Q4 2020 Feb 12, 2021	BUY	$112.16 - $174.14 $77,390 - $120,156	690 Added 239.58%	978 $169,000
Q1 2020 May 12, 2020	BUY	$57.05 - $95.75 $16,430 - $27,576	288 New	288 $19,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.15B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.